Abstract
NSAIDs are well known by their anti-inflammatory effects, where inhibition of NFκ-B is a central anti-inflammatory mechanism and by their anticancer effects via cyclooxygenases (COXs) inhibition. The polyphenol- and salicin-rich willow bark extract STW 33-I (water extract, 16–23:1) is successfully applied in the treatment of painful and inflammatory diseases. The aim of this study was to determine anticancer and anti-inflammatory effects of STW 33-I and its polyphenolic fraction E (Fr. E) compared to well characterized NSAIDs such as Aspirin (ASS) and Diclofenac.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
